| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | 0.26 | 0.05 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.062 | 0.05 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.078 | 0.05 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.079 | 0.05 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.062 | 0.05 |